Material Agreements

NCL CORP Ltd. terminated Secured Notes Indenture with U.S. Bank Trust Company, National Association valued at $250.0 million 9.75% Senior Secured Notes due 2028 repurchased and cancelled (effective 2024-03-11).

“On March 11, 2024, in connection with the settlement of the Repurchase, the Trustee cancelled the aggregate principal amount outstanding under the Secured Notes and confirmed that NCLC had satisfied and discharged its obligations under the Secured Notes Indenture.”

NCL CORP Ltd. entered into third amended and restated commitment letter with funds managed by affiliates of Apollo Global Management valued at $650.0 million senior unsecured notes due five years after issue date (effective 2024-03-11).

“On February 23, 2024, NCL Corporation Ltd. (“NCLC”) entered into a third amended and restated commitment letter (the “Amended Commitment Letter”) with funds managed by affiliates of Apollo Global Management (the “Apollo Funds”), which became effective on March 11, 2024 and which amends, restates and supersedes the second amended and restated commitment letter, dated February 22, 2023, among NCLC and the Apollo Funds.”

Lazard, Inc. entered into Underwriting Agreement with Citigroup Global Markets Inc., as representative of the several underwriters (effective 2024-03-06).

“On March 6, 2024, Lazard Group entered into an underwriting agreement (the “Underwriting Agreement”) with Citigroup Global Markets Inc., as representative of the several underwriters listed on Schedule I thereto (collectively, the “Underwriters”), pursuant to which Lazard Group agreed to sell and the Underwriters agreed to purchase, subject to and upon terms and conditions set forth therein, the Notes.”

Lazard, Inc. entered into Tenth Supplemental Indenture with The Bank of New York Mellon valued at $400,000,000 (effective 2024-03-12).

“On March 12, 2024, Lazard Group LLC (“Lazard Group”), a subsidiary of Lazard, Inc., completed its previously announced offering of an aggregate principal amount of $400,000,000 of Lazard Group’s 6.000% Senior Notes due 2031 (the “Notes”) in a registered public offering pursuant to Lazard Group’s shelf registration statement on Form S-3 (Registration No. 333-263578).”

CalEthos, Inc. entered into Exchange Agreement with 14 holders valued at $5,417,459.50 (effective 2023-12-11).

“Between December 11, 2023 and February 20, 2024, CalEthos Inc. (the “Company”) entered into a series of exchange subscription agreements (each, an “Exchange Agreement” and collectively, the “Exchange Agreements”) with 14 holders (each, a “Holder”) of the Company’s outstanding promissory notes and, in certain cases, related outstanding stock purchase warrants, pursuant to which the Company and the Holders agreed to exchange their promissory notes, and, if applicable, related stock purchase warrants, for shares of the Company’s common stock, par value $0.001per share (the “Common Stock”).”

PhaseBio Pharmaceuticals Inc entered into Plan Support and Settlement Agreement with SFJ Pharma X, Inc. (effective 2024-03-06).

“On March 6, 2024, the Company and SFJ executed and entered into a Plan Support and Settlement Agreement (the “Settlement Agreement”) to resolve the Motion to Allow, the Objection, and related matters.”

XEROX CORP entered into Indenture with U.S. Bank Trust Company, National Association valued at $350 million (effective 2024-03-11).

“the Company entered into an Indenture, dated March 11, 2024 (the “Indenture”), with Xerox Corporation and Xerox Business Solutions, LLC, as guarantors, and U.S. Bank Trust Company, National Association, as trustee.”

CoreCivic, Inc. entered into Supplemental Indenture with Equiniti Trust Company, LLC and the subsidiary guarantors set forth therein valued at $500 million aggregate principal amount of 8.250% senior unsecured notes due 2029 (effective 2024-03-12).

“the supplemental indenture dated as of March 12, 2024 (the “Supplemental Indenture”), by and among the Company, the Trustee, and the subsidiary guarantors set forth therein (the “Guarantors”).”

CoreCivic, Inc. entered into Base Indenture with Equiniti Trust Company, LLC valued at $500 million aggregate principal amount of 8.250% senior unsecured notes due 2029 (effective 2024-03-12).

“On March 12, 2024, CoreCivic, Inc., a Maryland corporation (the “Company”), completed the previously announced public offering (the “Notes Offering”) of $500 million aggregate principal amount of 8.250% senior unsecured notes due 2029 (the “Notes”), which are fully and unconditionally guaranteed, on a senior unsecured basis, by the Guarantors (as defined below) (the “Guarantees”).”

INTEST CORP entered into Lease Agreement with Elettra Real Estate S.r.l valued at €231,312 (effective 2024-03-12).

“In connection with the Purchase Agreement, Alfamation has entered into a lease agreement (the “Lease Agreement”) by and between Alfamation and Elettra Real Estate S.r.l , a limited liability company incorporated under the Laws of Italy (the “Landlord”).”

INTEST CORP entered into Purchase Agreement with Mauro Arigossi and Elettra S.S. valued at approximately €20 million (effective 2024-03-12).

“On March 12, 2024 inTEST Corporation (the “Company”) entered into a stock purchase agreement (the “Purchase Agreement”) by and among inTEST Italy, Inc., a wholly owned subsidiary of the Company (“Buyer”), Mauro Arigossi (“Arigossi”), and Elettra S.S., a company incorporated under the Laws of Italy (“Elettra”, and together with Arigossi, each a “Seller” and collectively, the “Sellers”).”

DYNAVAX TECHNOLOGIES CORP entered into Office/Laboratory Lease with Emery Station West, LLC valued at lease of approximately 75,662 sq ft at 5959 Horton Street, Emeryville, California (effective 2018-09-17).

“on September 17, 2018, Dynavax Technologies Corporation (the “Company”) entered into an Office/Laboratory Lease (“Master Lease”) with Emery Station West, LLC (“Master Landlord”) to lease approximately 75,662 square feet of office/laboratory space located at 5959 Horton Street, Emeryville, California (“Premises”).”

DYNAVAX TECHNOLOGIES CORP terminated Termination and Release Agreement with Zymergen Inc. and Metagenomi, Inc. valued at termination of Zymergen Sublease effective upon satisfaction of conditions precedent (effective 2024-02-22).

“the Company, Zymergen and Metagenomi, Inc. (“Metagenomi”) entered into that certain Termination and Release Agreement dated February 22, 2024 (the “Termination Agreement”), pursuant to which the Zymergen Sublease will terminate effective as of the date the conditions precedent set forth in the Termination Agreement have been satisfied.”

DYNAVAX TECHNOLOGIES CORP entered into Sublease with Metagenomi, Inc. valued at initial monthly base rate $493,354.08 with 50% abatement through June 30, 2024, term through March 3 (effective 2024-03-07).

“On March 7, 2024, the Company, as sublandlord, entered into a sublease (the “Sublease”) with Metagenomi, as subtenant, for the Premises.”

WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP entered into Twelfth Supplemental Indenture to the Indenture dated as of August 8, 2013, for 5.611% Senior Notes due 2034 with Computershare Trust Company, National Association; U.S. Bank Trust Company, National Association valued at $500,000,000 aggregate principal amount of 5.611% Senior Notes due 2034 (effective 2024-03-11).

“On March 11, 2024, Westinghouse Air Brake Technologies Corporation (the “Company”) completed a public offering and sale of $500,000,000 aggregate principal amount of the Company’s 5.611% Senior Notes due 2034 (the “notes”).”

Enveric Biosciences, Inc. entered into Purchase Agreement with certain institutional investors (effective 2024-03-08).

“On March 8, 2024, Enveric Biosciences, Inc., a Delaware corporation (the “Company”) entered into a series of common stock purchase agreements (the “Purchase Agreement”) for the issuance in a registered direct offering of 228,690 shares of the Company’s common stock, par value $0.01 per share (the “Shares”), to certain institutional investors.”

FOMO WORLDWIDE, INC. terminated a credit facility with Thermo Communications Funding, LLC valued at $1,074,276.15 (effective 2024-01-04).

“On January 4, 2024, Thermo Communications Funding, LLC (“Thermo”) defaulted us and our subsidiary SMARTSolution Technologies, Inc. (“SST”), terminated its senior secured asset backed lending agreement executed with us on February 28, 2022, and subsequently obtained a confession of judgment against us and certain of our subsidiaries.”

HEALTHPEAK PROPERTIES, INC. amended Sales Agreement with J.P. Morgan Securities LLC, Robert W. Baird & Co. Incorporated, Barclays Capital Inc., BNP Paribas Securities Corp., BofA Securities, Inc., BTIG, LLC, Capital One Securities, Inc., Credit Agricole Securities (USA) Inc., Goldman Sachs & Co. LLC, Jefferies LLC, Mizuho Securities USA LLC, Morgan Stanle valued at up to $1,500,000,000 (effective 2024-03-11).

“On March 11, 2024, Healthpeak Properties, Inc., a Maryland corporation (the “Company”), and Healthpeak OP, LLC, a Maryland limited liability company (the “operating company”), entered into an amendment (the “Amendment”) to the “at-the market” equity offering sales agreement (the “Sales Agreement”) with each of J.P. Morgan Securities LLC, Robert W. Baird & Co. Incorporated, Barclays Capital Inc., BNP Paribas Securities Corp., BofA Securities, Inc., BTIG, LLC, Capital One Securities, Inc., Credit Agricole Securities (USA) Inc., Goldman Sachs & Co. LLC, Jefferies LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, RBC Capital Markets, LLC, Regions Securities LLC, Scotia Capital (USA) Inc., TD Securities (USA) LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC”

IPALCO ENTERPRISES, INC. entered into IPALCO Purchase Agreement with J.P. Morgan Securities LLC, PNC Capital Markets LLC and U.S. Bancorp Investments, Inc., as representatives valued at $400 million (effective 2024-03-08).

“on March 8, 2024, IPALCO entered into a purchase agreement (the “IPALCO Purchase Agreement”) with the Representatives, as representatives of the several initial purchasers named therein (the “IPALCO Initial Purchasers”), relating to the sale by IPALCO of $400 million aggregate principal amount of senior secured notes (the “Notes”) at an annual interest rate of 5.750%.”

IPALCO ENTERPRISES, INC. entered into AES Indiana Purchase Agreement with J.P. Morgan Securities LLC, PNC Capital Markets LLC and U.S. Bancorp Investments, Inc., as representatives valued at $650 million (effective 2024-03-07).

“On March 7, 2024, the principal subsidiary of IPALCO Enterprises, Inc. (“IPALCO”), Indiana Power & Light Company, d/b/a AES Indiana (“AES Indiana”) entered into a purchase agreement (the “AES Indiana Purchase Agreement”) with J.P. Morgan Securities LLC, PNC Capital Markets LLC and U.S. Bancorp Investments, Inc., as representatives (collectively, the “Representatives”) of the several initial purchasers named therein (the “AES Indiana Initial Purchasers”), relating to the previously announced offering by AES Indiana of $650 million aggregate principal amount of First Mortgage Bonds (the “Bonds”) at an annual interest rate of 5.700%.”

China Solar & Clean Energy Solutions, Inc. entered into Asset Purchase Agreement with Easy Modular Manufacturing, Inc valued at cash consideration and contingent consideration (effective 2024-03-05).

“On March 5, 2024, China Solar & Clean Energy Solutions, Inc (the “Company) entered into an asset purchase agreement (the “Asset Purchase Agreement”) with Easy Modular Manufacturing, Inc (“Easy Modular Manufacturing”) for the purchase of the asset Easy Nano-Void Injection System Modular (the “Product”).”

PAR TECHNOLOGY CORP entered into Scheme Implementation Agreement with TASK Group Holdings Limited valued at AUD$0.81 per TASK Share or 0.015 shares of PAR common stock per TASK Share (effective 2024-03-08).

“On March 8, 2024 (Eastern Standard Time) / March 9, 2024 (Sydney Time), PAR and TASK Group Holdings Limited, an Australian public company limited by shares and listed on the Australian Securities Exchange (“TASK”), entered into a Scheme Implementation Agreement (the “ SIA ”), pursuant to which, subject to the satisfaction or waiver of the conditions set forth therein, PAR or its nominee (“ PAR Acquiror ”) will acquire all TASK ordinary shares (the “ TASK Shares ”) pursuant to a court-approved scheme of arrangement under Part 5.1 of Australia’s Corporations Act 2001 (Cth) (“ Corporations Act ”) (the “ TASK Scheme ” and such acquisition, the “ TASK Transaction ”).”

PAR TECHNOLOGY CORP entered into Purchase Agreement with Longshore Capital Fund I, L.P. valued at $170 million in cash and 441,598 common shares (effective 2024-03-08).

“On March 8, 2024 (the “ Signing/Closing Date ”), PAR Technology Corporation, a Delaware corporation (“ PAR ”), and ParTech, Inc., a New York corporation (the “ ParTech ”) and a wholly owned subsidiary of PAR, entered into a Purchase Agreement (the “ Purchase Agreement ”) with the persons identified as Company Sellers on the signature pages thereto, Longshore Capital Fund I, L.P., a Delaware limited partnership (collectively, the “ Stuzo Sellers ”), and Longshore Capital Management, LLC, a Delaware limited liability company, in its capacity as the Seller Representative.”

EQT Corp entered into Agreement and Plan of Merger with Equitrans Midstream Corporation (effective 2024-03-10).

“On March 10, 2024, EQT Corporation, a Pennsylvania corporation (“EQT”), Humpty Merger Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of EQT (“Merger Sub”), Humpty Merger Sub LLC, a Delaware limited liability company and an indirect wholly owned subsidiary of EQT (“LLC Sub”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Equitrans Midstream Corporation, a Pennsylvania corporation (“Equitrans”).”

NIKE, Inc. terminated Prior 364‐Day Credit Agreement with the banks, financial institutions and other lenders signatory thereto valued at up to $1.0 billion (effective 2024-03-08).

“On March 8, 2024, concurrently with the Company’s entry into the 364-Day Credit Agreement described in Item 1.01 hereof, the Company terminated the existing Credit Agreement dated March 10, 2023, which provided for up to $1.0 billion of borrowings in U.S. Dollars pursuant to a 364‐day unsecured revolving credit facility, with the banks, financial institutions and other lenders signatory thereto (the “Prior 364‐Day Credit Agreement”).”

NIKE, Inc. entered into 364‐Day Credit Agreement with Bank of America, N.A., as administrative agent, and the other financial institutions named therein as lenders valued at up to $1.0 billion (effective 2024-03-08).

“On March 8, 2024, NIKE, Inc. (the “Company”) entered into a Credit Agreement with Bank of America, N.A., as administrative agent, and the other financial institutions named therein as lenders (the “364‐Day Credit Agreement”).”

RenX Enterprises Corp. entered into Credit Agreement with Bryan Leighton Revocable Trust Dated December 13th, 2023 valued at up to the maximum amount of $250,000 (effective 2024-03-01).

“On March 1, 2024 Safe and Green Development Corporation (the "Company") entered into a credit agreement (the “Credit Agreement”) with the Bryan Leighton Revocable Trust Dated December 13th, 2023 (the “Lender”) pursuant to which the Lender agreed to provide the Company with a line of credit facility (the “Line of Credit”) up to the maximum amount of $250,000”

Lexeo Therapeutics, Inc. entered into Common Stock Purchase Agreement with certain qualified institutional buyers and institutional accredited investors valued at approximately $95 million (effective 2024-03-11).

“On March 11, 2024, Lexeo Therapeutics, Inc. (the “ Company ”) entered into a Common Stock Purchase Agreement (the “ Purchase Agreement ”) for a private placement (the “ Private Placement ”) with certain qualified institutional buyers and institutional accredited investors (each, a “ Purchaser ” and collectively, the “ Purchasers ”).”

Signing Day Sports, Inc. amended Amendment No. 1 to Strategic Alliance Agreement with SAJE Enterprises LLC (DBA Elite Development Program Soccer) (effective 2024-03-08).

“On March 8, 2024, Signing Day Sports, a Delaware corporation (the “Company”), entered into Amendment No. 1 to Strategic Alliance Agreement (the “Amendment to the Strategic Alliance Agreement”) with SAJE Enterprises LLC (DBA Elite Development Program Soccer), a New Jersey limited liability company (“EDP”).”

NEXTNAV INC. entered into Asset Purchase Agreement with Telesaurus Holdings GB and Skybridge Spectrum Foundation valued at up to $50,000,000 (effective 2024-03-07).

“On March 7, 2024, NextNav Inc. (“NextNav”) and its wholly-owned subsidiary Progeny LMS, LLC (the “Company”) entered into an Asset Purchase Agreement (the “Agreement”) with Telesaurus Holdings GB (“Telesaurus”) and Skybridge Spectrum Foundation (“Skybridge”), pursuant to which the Company will acquire (1) Multilateration Location and Monitoring Service (“M-LMS”) licenses (the “Licenses”) issued by the Federal Communications Commission (the “FCC”) and (2) rights to a petition for reconsideration, dated December 20, 2017, which, if granted, may reinstate additional M-LMS licenses owned by Skybridge and Telesaurus and terminated by the FCC in 2017, for an aggregate purchase price of up to $50,000,000 paid in the form of cash and NextNav common stock”

Rigel Resource Acquisition Corp. entered into Exchange Agreement with Newco, Blyvoor Gold Proprietary Limited, Orion Mine Finance Fund II L.P., and the Target Companies (effective 2024-03-11).

“Concurrently with the execution of the Business Combination Agreement, Newco also entered into an Exchange Agreement (the “ Exchange Agreement ”), by and among, Newco, Blyvoor Gold Proprietary Limited, a South African private limited liability company (“ Blyvoor Gold ”), Orion Mine Finance Fund II L.P., a Bermuda limited partnership (“ Orion ” and, together with Blyvoor Gold, the “ Sellers ”), and the Target Companies.”

Rigel Resource Acquisition Corp. entered into Business Combination Agreement with Rigel, Blyvoor Gold Resources Proprietary Limited, Blyvoor Gold Operations Proprietary Limited, RRAC NewCo, and RRAC Merger Sub (effective 2024-03-11).

“On March 11, 2024, Rigel Resource Acquisition Corp, a Cayman Islands exempted company (“ Rigel ”), entered into a Business Combination Agreement (the “ Business Combination Agreement ”), by and among Rigel, Blyvoor Gold Resources Proprietary Limited, a South African private limited liability company (“ Blyvoor Resources ”), Blyvoor Gold Operations Proprietary Limited, a South African private limited liability company (“ Tailings ” and, together with Blyvoor Resources, the “ Target Companies ”, each a “ Target Company ”), RRAC NewCo, a Cayman Islands exempted company and wholly-owned subsidiary of Rigel (“ Newco ”), and RRAC Merger Sub, a Cayman Islands exempted company and wholly-owned subsidiary of Newco (“ Merger Sub ”).”

Mountain & Co. I Acquisition Corp. amended Trust Agreement Amendment No. 3 with Continental Stock Transfer & Trust Company (effective 2024-03-08).

“On March 8, 2024, upon the shareholders’ approval of the Trust Amendment Proposal (as defined below), Mountain & Co. I Acquisition Corp. (the “Company”), entered into an amendment (the “Trust Agreement Amendment No. 3”) to the Investment Management Trust Agreement, dated November 4, 2021 (as amended by Amendment No. 1 dated February 6, 2023 and Amendment No. 2 dated September 14, 2023, the “Trust Agreement”), by and between the Company and Continental Stock Transfer & Trust Company, as trustee, to allow the change of the date by which the Company must consummate its initial business combination from March 9, 2024 to November 9, 2024 (or such earlier date as determined by the Company’s board of directors) (the “Extension”).”

Alpha Teknova, Inc. amended Amendment No. 5 with MidCap Financial Trust valued at $52.135 million senior secured term loan and a $5.0 million working capital facility (effective 2024-03-08).

“On March 8, 2024, Alpha Teknova, Inc. (the “Company”) entered into limited waivers and amendments (collectively “Amendment No. 5”) to (i) the May 10, 2022, Amended and Restated Credit and Security Agreement (Term Loan)”

Greenidge Generation Holdings Inc. entered into Motus Agreement with a subsidiary of Motus Pivot Inc. valued at $1.45 million (effective 2024-03-06).

“On March 6, 2024, a subsidiary of Greenidge Generation Holdings Inc. (“ Greenidge ” or the " Company ") entered into a Commercial Purchase and Sale Agreement (the “ Motus Agreement ”) with a subsidiary of Motus Pivot Inc., a Delaware corporation (" Motus "), pursuant to which Greenidge has agreed to purchase from Motus a parcel of land containing approximately 12 acres located in Columbus, Mississippi, including over 73,000 square feet of industrial warehouse space (the “ Property ”).”

CONX Corp. entered into Purchase Agreement with EchoStar Real Estate Holding L.L.C. valued at $26.75 million (effective 2024-03-10).

“On March 10, 2024, CONX Corp. (the “Company”), a special purpose acquisition company, and EchoStar Real Estate Holding L.L.C. (“Seller”), a subsidiary of EchoStar Corporation, entered into a definitive purchase and sale agreement (the “Purchase Agreement”), which provides for the Company’s purchase from the Seller of the commercial real estate property (the “Property”) in Littleton, Colorado, comprising the corporate headquarters of DISH Wireless, for a purchase price of $26.75 million (the “Purchase Price” and such transaction, the “Transaction”).”

Definium Therapeutics, Inc. entered into Purchase Agreement with certain investors valued at approximately $70.3 million (effective 2024-03-07).

“Also on March 7, 2024, the Company entered into a securities purchase agreement (the “Purchase Agreement”) with certain investors (the “Investors”), pursuant to which the Investors agreed to purchase, and the Company agreed to sell 12,500,000 common shares (the “Private Placement Shares”), at a price of $6.00 per Private Placement Share, in a private placement transaction (the “Private Placement”).”

Definium Therapeutics, Inc. entered into Underwriting Agreement with Leerink Partners LLC and Cantor Fitzgerald & Co., as representatives of the underwriters named therein valued at approximately $93.8 million (effective 2024-03-07).

“On March 7, 2024, Mind Medicine (MindMed) Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Leerink Partners LLC and Cantor Fitzgerald & Co., as representatives of the underwriters named therein (the “Underwriters”), in connection with the issuance and sale by the Company in an underwritten offering (the “Offering”) of 16,666,667 common shares”

Blue Owl Credit Income Corp. amended Amendment No. 7 with Core Income Funding II LLC (effective 2024-03-07).

“In connection with the CLO Transaction, on March 7, 2024, Core Income Funding II LLC, entered into Amendment No. 7 (the “Amendment” and the facility as amended, the “Secured Credit Facility”), which amended that certain Loan Financing and Servicing Agreement, dated as of October 5, 2021”

Blue Owl Credit Income Corp. entered into Collateral Management Agreement with Blue Owl Credit Advisors LLC (effective 2024-03-07).

“OCA will serve as collateral manager for the Issuer under a collateral management agreement dated as of the Closing Date (the “Collateral Management Agreement”).”

Blue Owl Credit Income Corp. entered into Core Income Funding II Loan Sale Agreement with Core Income Funding II LLC valued at approximately $356.49 million (effective 2024-03-07).

“The remainder of the initial portfolio assets securing the Secured Notes consisted of approximately $356.49 million funded par amount of middle market loans purchased by the Issuer from Core Income Funding II LLC, a wholly-owned subsidiary of the Company, under an additional loan sale agreement executed on the Closing Date between the Issuer and Core Income Funding II LLC (the “Core Income Funding II Loan Sale Agreement”).”

Blue Owl Credit Income Corp. entered into OCIC Loan Sale Agreement with Owl Rock CLO XVI, LLC valued at approximately $206.563 million (effective 2024-03-07).

“As part of the CLO Transaction, the Company entered into a loan sale agreement with the Issuer dated as of the Closing Date (the “OCIC Loan Sale Agreement”), which provided for the contribution of approximately $206.563 million funded par amount of middle market loans from the Company to the Issuer on the Closing Date and for future sales from the Company to the Issuer on an ongoing basis.”

Blue Owl Credit Income Corp. entered into Indenture with State Street Bank and Trust Company valued at $597 million (effective 2024-03-07).

“On March 7, 2024 (the “Closing Date”), Blue Owl Credit Income Corp. (the “Company”) completed a $597 million term debt securitization transaction (the “CLO Transaction”), also known as a collateralized loan obligation transaction, which is a form of secured financing incurred by the Company.”

Kiromic Biopharma, Inc. entered into 25% Senior Secured Convertible Promissory Note with an accredited investor valued at principal amount of $2,000,000 (effective 2024-03-07).

“On March 7, 2024, Kiromic BioPharma, Inc. (the “Company”) issued a 25% Senior Secured Convertible Promissory Note (the “Note”) to an accredited investor. The Note has a principal amount of $2,000,000”

Equitrans Midstream Corp entered into Agreement and Plan of Merger with EQT Corporation, Humpty Merger Sub Inc., Humpty Merger Sub LLC (effective 2024-03-10).

“On March 10, 2024, Equitrans Midstream Corporation, a Pennsylvania corporation (the Company), EQT Corporation, a Pennsylvania corporation (Parent), Humpty Merger Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent (Merger Sub), and Humpty Merger Sub LLC, a Delaware limited liability company and an indirect wholly owned subsidiary of Parent (LLC Sub and, together with Merger Sub, Merger Subs), entered into an Agreement and Plan of Merger (the Merger Agreement)”

Arcosa, Inc. entered into Membership Interest Purchase Agreement with National Oilwell Varco, L.P. valued at approximately $180 million (effective 2024-03-08).

“On March 8, 2024, CEMC Services, LLC (“Purchaser”), a Delaware limited liability company and wholly owned subsidiary of Arcosa, Inc. (“Arcosa”), entered into a Membership Interest Purchase Agreement (the “Purchase Agreement”) with National Oilwell Varco, L.P., a Delaware limited partnership (the “Seller”) and, solely for the purposes of Section VI.3(c) (Confidentiality) and Section VI.12 (Buyer Guarantor), Arcosa.”

Harpoon Therapeutics, Inc. terminated Controlled Equity Offering SM Sales Agreement with Cantor Fitzgerald & Co. (effective 2024-03-11).

“As previously disclosed, on March 13, 2020, Harpoon entered into a Controlled Equity Offering SM Sales Agreement (the “Sales Agreement”) with Cantor Fitzgerald & Co.”

Axil Brands, Inc. entered into Repurchase Agreements with stockholders of the Company listed on the signature pages valued at $1,246,489.50 (effective 2024-03-05).

“Effective as of March 5, 2024, AXIL Brands, Inc. (the “Company”) entered into repurchase agreements (the “Repurchase Agreements”) with the stockholders of the Company listed on the signature pages thereto (the “Stockholders”) to purchase from the Stockholders in the aggregate 207,748,250 shares of Series A Preferred Stock of the Company (equivalent, in the aggregate, to approximately 10,387,413 shares of the Company’s common stock on an as converted basis) for the aggregate cash consideration of $1,246,489.50.”

California Resources Corp amended Amendment with Citibank, N.A., as administrative agent, collateral agent and issuing bank, and the several lenders party thereto (effective 2024-03-08).

“On March 8, 2024, California Resources Corporation (the “Company” or “CRC”) entered into a third amendment (the “Amendment”) to its Amended and Restated Credit Agreement, dated as of April 26, 2023, with Citibank, N.A., as administrative agent, collateral agent and issuing bank, and the several lenders party thereto (as amended, the “Revolving Credit Facility”).”

Goldman Sachs BDC, Inc. entered into Underwriting Agreement with Goldman Sachs Asset Management, L.P. and BofA Securities, Inc., as representative of the several underwriters valued at $400,000,000 aggregate principal amount of 6.375% notes due 2027 (effective 2024-03-06).

“On March 6, 2024, Goldman Sachs BDC, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) by and among the Company, Goldman Sachs Asset Management, L.P. and BofA Securities, Inc., as representative of the several underwriters named in Schedule A thereto (collectively, the “Underwriters”), in connection with the issuance and sale of $ 400,000,000 aggregate principal amount of the Company’s 6.375% notes due 2027 (the “Offering”).”